The reported adverse event / incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event / incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number / lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event / incident.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event / incident was completed.An examination of medical records and / or medical imaging received by endologix shows an urgent presentation, occlusion of the aortic stent graft, and secondary endovascular procedure event / incident being confirmed.This is consistent with the reported adverse event / incident.The most likely causation for the reported complete occlusion below the renal arteries is likely anatomy related due to the pre-existing condition of aiod (aorto-iliac occlusive disease).The final patient status was reported as doing well.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events / incidents.Device iteration is afx2.Corrections: g1, 2: contact office- name has been updated.G4: date of received by manufacturer.H6: result code: remove code 3233.H6: conclusion code: remove code 11.
|